![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Smithkline Beecham Pharmaceuticals Irvine Gb, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Potassium clavulanate, diluted, silica, colloidal hydrated in a ratio 1:1, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2006-068 - Rev 01
This Chemical Type CEP, issued on February 02, 2010, remains in force until March 28, 2011, ensuring its reliability within the pharmaceutical industry.
Substance Number 1653 associated with this CEP further emphasizes